Records containing: Leptomeningeal Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-27Traditional Incision and Drainage of Cutaneous Abscess Vs. Minimally Invasive Incision and Drainage With Vessel Loop: A Randomized Controlled Trail
-
CLINICAL_TRIALS study record update · 2026-04-14Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease
-
CLINICAL_TRIALS study record update · 2026-04-08Deutsches Meningeosis Neoplastica Register
-
CLINICAL_TRIALS study record update · 2026-04-01A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) Administered Intrathecally (IT) Primed Against HER2/HER3 in Patients With Leptomeningeal Disease (LMD) From Triple-Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC)
-
CLINICAL_TRIALS study record update · 2026-03-23Traditional Incision and Drainage of Cutaneous Abscess Vs. Minimally Invasive Incision and Drainage With Vessel Loop: A Randomized Controlled Trail
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-02Phase IB Study of Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
-
CLINICAL_TRIALS study record update · 2026-02-09Phase I/II Study of Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in the Management of HER2+ Breast Leptomeningeal Disease
-
CLINICAL_TRIALS study record update · 2026-02-05A Phase 1/1b Study of Autologous b7-h3 Chimeric Antigen Receptor t Cells (b7-h3.cd28z.Cart) in Children and Young Adults With Recurrent or Progressive Cns Neoplasms Expressing b7-h3 Target
-
CLINICAL_TRIALS study record update · 2025-12-23Phase IIa Study Assessing QBS72S For Treating Brain Metastases
-
CLINICAL_TRIALS study record update · 2025-11-18Multicentric Single Arm Phase II Study Evaluating the Efficacy of Association of Tucatinib, Capecitabine and Intra-CSF Trastuzumab in HER2 Amplified Breast Cancer Patients With Leptomeningeal Metastases
-
CLINICAL_TRIALS study record update · 2025-04-03Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
-
CLINICAL_TRIALS study record update · 2024-05-16Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
-
CLINICAL_TRIALS study record update · 2023-10-16A Longitudinal Therapy Response Monitoring Study in Subjects With Leptomeningeal Metastases Using CNSide (CSF Tumor Cells) Compared to Standard of Care (CSF Cytology, Clinical Evaluation, and Imaging).
-
CLINICAL_TRIALS study record update · 2023-02-08A Phase II Non-randomized Study to Assess the Safety and Efficacy of the Combination of Tucatinib and Trastuzumab and Capecitabine for Treatment of Leptomeningeal Metastases in HER2 Positive Breast Cancer
-
CLINICAL_TRIALS study record update · 2022-06-14A Dose Finding Study of Continuous and Intermittent High-dose (HDI) Afatinib (EGFR TKI) on CNS Metastases and Leptomeningeal Disease (LMD) in Patients With Advanced Refractory EGFR Mutation Positive Non-small Cell Lung Cancer